GRDX
NASDAQ HealthcareGridAI Technologies Corp. - Common Stock
Biotechnology
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
๐ Market Data
| Price | $5.45 |
|---|---|
| Volume | 198,747 |
| Market Cap | 48.44M |
| RSI (14-Day) | 57.3 |
| 200-Day MA | $3.51 |
| 50-Day MA | $3.98 |
| 52-Week High | $6.93 |
| 52-Week Low | $1.87 |
๐ฏ Investment Strategy Scores
GRDX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (51/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (9/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find GRDX in your text
Paste any article, transcript, or post โ the tool will extract GRDX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-10-29.